Ireland cancer trial participation below half of national target, costing savings

A report finds that Irish cancer patient enrollment in clinical trials is less than half the national target, despite trials saving the state €6.5m in treatment costs over 12 months. The gap suggests missed opportunities for both patient access and cost efficiency. The cause of the shortfall is not specified, but likely relates to capacity or referral patterns.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works